CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases (Q42605598)

3 November 2017

CP-481,715, a potent and selective CCR1 antagonist with potential therapeutic implications for inflammatory diseases (English)

1 reference

3 November 2017

Ronald P Gladue

1

1 reference

3 November 2017

Laurie A Tylaska

2

1 reference

3 November 2017

William H Brissette

3

1 reference

3 November 2017

Paul D Lira

4

1 reference

3 November 2017

John C Kath

5

1 reference

3 November 2017

Christopher S Poss

6

1 reference

3 November 2017

Matthew F Brown

7

1 reference

3 November 2017

Timothy J Paradis

8

1 reference

3 November 2017

Maryrose J Conklyn

9

1 reference

3 November 2017

Kevin T Ogborne

10

1 reference

3 November 2017

Molly A McGlynn

11

1 reference

3 November 2017

Brett M Lillie

12

1 reference

3 November 2017

Amy P DiRico

13

1 reference

3 November 2017

Erin N Mairs

14

1 reference

3 November 2017

Eric B McElroy

15

1 reference

3 November 2017

William H Martin

16

1 reference

3 November 2017

Ingrid A Stock

17

1 reference

3 November 2017

Richard M Shepard

18

1 reference

3 November 2017

Henry J Showell

19

1 reference

3 November 2017

Kuldeep Neote

20

1 reference

3 November 2017

language of work or name

English

0 references

publication date

7 August 2003

1 reference

Journal of Biological Chemistry

3 November 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

3 November 2017

278

1 reference

3 November 2017

40473-40480

1 reference

3 November 2017

42

1 reference

The saga of the discovery of IL-1 and TNF and their specific inhibitors in the pathogenesis and treatment of rheumatoid arthritis

3 November 2017

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

The pathogenesis of rheumatoid arthritis: a guide to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Chemokine receptors: multifaceted therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Chemokines and T lymphocytes: more than an attraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Chemokine stimulation of monocyte matrix metalloproteinase-9 requires endogenous TNF-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Macrophage inflammatory protein-1 alpha. A novel chemotactic cytokine for macrophages in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Differential expression of chemokine receptors on peripheral blood, synovial fluid, and synovial tissue monocytes/macrophages in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Polyclonal antibody directed against human RANTES ameliorates disease in the Lewis rat adjuvant-induced arthritis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Agonist-independent activation of Gz by the 5-hydroxytryptamine1A receptor co-expressed in Spodoptera frugiperda cells. Distinguishing inverse agonists from neutral antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Chemokine receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Identification and characterization of a potent, selective, and orally active antagonist of the CC chemokine receptor-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Control of leukocyte rolling velocity in TNF-alpha-induced inflammation by LFA-1 and Mac-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Effect of a CC chemokine receptor antagonist on collagen induced arthritis in DBA/1 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 alpha and MIP-1 beta on human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

In vitro migration of mononuclear cells towards synovial fluid and plasma from rheumatoid arthritis patients correlates to RANTES synovial fluid levels and to clinical pain parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

RANTES expression and contribution to monocyte chemotaxis in arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

The chemoattractant activity of rheumatoid synovial fluid for human lymphocytes is due to multiple cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Chemokine-dependent upregulation of CD11b on specific leukocyte subpopulations in human whole blood: effect of anticoagulant on rantes and MIP-1 beta stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

Leukocyte recruitment during onset of experimental allergic encephalomyelitis is CCR1 dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M306875200

21 January 2018

Identifiers

DOI

10.1074/JBC.M306875200

1 reference

3 November 2017

1 reference